Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Shares Outstanding (Diluted Average) (2019 - 2025)

Neuronetics (STIM) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $66.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 107.82% to $66.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66.0 million through Dec 2025, up 107.82% year-over-year, with the annual reading at $66.0 million for FY2025, 107.82% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $66.0 million at Neuronetics, down from $67.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $67.3 million in Q3 2025, with the low at $25.2 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $35.2 million, with a median of $28.4 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Diluted Average) increased 2.52% in 2022, then surged 124.88% in 2025.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $25.5 million in 2021, then increased by 5.58% to $26.9 million in 2022, then increased by 6.54% to $28.7 million in 2023, then increased by 10.73% to $31.7 million in 2024, then soared by 107.82% to $66.0 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $66.0 million, $67.3 million, and $63.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.